Your browser doesn't support javascript.
loading
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia.
Miyagawa, Naoyuki; Goto, Hiroaki; Ogawa, Atsushi; Kikuta, Atsushi; Kosaka, Yoshiyuki; Sekimizu, Masahiro; Tomizawa, Daisuke; Toyoda, Hidemi; Hiramatsu, Hidefumi; Hara, Junichi; Mochizuki, Shinji; Nakayama, Hideki; Yoshimura, Kenichi; Iijima-Yamashita, Yuka; Sanada, Masashi; Ogawa, Chitose.
Afiliación
  • Miyagawa N; Division of Hematology and Oncology, Kanagawa Children's Medical Center, 2-138-4 Mutsukawa, Minami-Ku, Yokohama, Kanagawa, 232-8555, Japan. nmiyagawa@kcmc.jp.
  • Goto H; Division of Hematology and Oncology, Kanagawa Children's Medical Center, 2-138-4 Mutsukawa, Minami-Ku, Yokohama, Kanagawa, 232-8555, Japan.
  • Ogawa A; Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan.
  • Kikuta A; Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan.
  • Kosaka Y; Department of Hematology and Oncology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
  • Sekimizu M; Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Tomizawa D; Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Toyoda H; Department of Pediatrics, Mie University Graduate School of Medicine, Mie, Japan.
  • Hiramatsu H; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hara J; Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan.
  • Mochizuki S; Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan.
  • Nakayama H; Department of Pediatrics, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Yoshimura K; Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.
  • Iijima-Yamashita Y; Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Sanada M; Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Ogawa C; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.
Int J Hematol ; 118(2): 267-276, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37127801
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials Límite: Child / Humans Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials Límite: Child / Humans Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón